Oria Bioscience is a pioneering French TechBio company expert in generating organelles.
We deliver high-quality, intact living organelles, surrounded by their therapeutic membrane targets. For the first time, organelles are being distributed globally and are fully compatible with high-throughput screening campaigns and drug development efforts.
Thanks to our microfluidics technology, we supply pharmaceutical laboratories and CROs with purified organelles (lysosomes, mitochondria, and endoplasmic reticulum). Working directly with organelles improves efficacy results, reduces attrition rates in clinical phases, accelerates Hit-to-Lead and Lead Optimization phases, and minimizes your carbon footprint by reducing resources used.
Oria’s team brings together over 50 years of expertise in organelles and microfluidics, dedicated to delivering organelles worldwide to meet drug discovery needs.
We are making organelles as accessible as cells, driving innovation across all health sectors.
Company Details
- Employees
- 14
- Founded
- -
- Address
- 6, Rue Jean Calvin, Paris,île-De-France 75005,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Strasbourg.
- HQ
- Paris, Île-de-France
Oria Bioscience Questions
Oria Bioscience's LinkedIn profile is https://fr.linkedin.com/company/oria-bioscience
Oria Bioscience has
14 employees.
View email and phone details for 14
employees at Oria Bioscience.
Oria Bioscience's industry is
Biotechnology Research
Oria Bioscience's top competitors are
Syntopia,
A.f. Genese,
Clarity,
Kwit,
Raidium,
Generare,
Deski,
Apertum Neuroscience®,
Lutèce Dynamics,
Cgenetix.
Oria Bioscience's categories are Biotechnology Research
Oria Bioscience's founding year is 2024
